---
title: "NP90726l Tildrakizumab (Ilumetri(r))"
ocid: "ocds-r6ebe6-0000823248"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000823248"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000823248.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000823248.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)"
published: "2026-03-17"
---

# NP90726l Tildrakizumab (Ilumetri(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)  
Current stage: Award  
OCID: ocds-r6ebe6-0000823248

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000823248)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000823248.json)

## Summary

The Common Services Agency, known as NHS National Services Scotland (NSS), has awarded a contract for the supply of Tildrakizumab (Ilumetri®) to NHS Scotland, with Almirall Ltd as the supplier. Classified under the health industry category, this procurement process covers entities outlined by the National Health Service (Scotland) Act 1978 and those formed under the Public Bodies (Joint Working) Scotland Act. With the procurement method being limited due to exclusive rights, the process bypassed a prior call for competition. The contract was signed on 16 March 2026, marking the transition from the tender to the award stage, and involves a substantial investment of £844,250 GBP. Located in Edinburgh, the buying organisation offers a crucial opportunity for suppliers in the health sector to contribute to Scotland's public health services.

This tender presents a significant opportunity for companies dealing in pharmaceuticals and healthcare supplies, particularly those offering specialised medications under intellectual property rights. Suitable businesses include large pharmaceutical firms capable of satisfying the specialised requirements of NHS Scotland. By engaging in this contract, businesses can solidify their presence in the Scottish healthcare market and potentially expand their influence. Through participation in such contracts, suppliers can leverage long-term framework agreements to ensure consistent and stable demand for their products, thereby fostering growth and development within the sector.

## Notice

Supply of Tildrakizumab (Ilumetri(r)) to NHS Scotland.

### Lot Information

Lot 1

Supply of Tildrakizumab (Ilumetri(r)) to NHS Scotland. The Authority has awarded this framework as a single supplier Framework per line to one (1) Framework Participant.

### Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR551912 |
| Notice type | OJEU - F15 - Voluntary Ex Ante Transparency Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 17 Mar 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 16 Mar 2026 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £844,250 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ALMIRALL |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 17 Mar 2026 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR551912

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR551912
  NP90726l Tildrakizumab (Ilumetri(r)) - Supply of Tildrakizumab (Ilumetri(r)) to NHS Scotland.

## Notice URLs

- http://
- http://www.nss.nhs.scot/browse/procurement-and-logistics
- http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=823248
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000823248

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000823248. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000823248.json.